About Malignant Sertoli-Leydig cell tumor of the ovary
Malignant Sertoli-Leydig cell tumor of the ovary is a rare disease catalogued by Orphanet (ORPHA:99916). It is associated with the DICER1 gene. Search below for active recruiting clinical trials from ClinicalTrials.gov, or visit the Orphanet expert page for specialist centres, natural history studies, and patient registries.
Clinical Trial Eligibility Tips
What to know before applying to Malignant Sertoli-Leydig cell tumor of the ovary trials.
Search ClinicalTrials.gov for "Malignant Sertoli-Leydig cell tumor of the ovary" or filter by Orphanet code ORPHA:99916 to find disease-specific studies.
Ask your specialist to refer you to a Centre of Expertise — Orphanet lists all accredited centres for this condition worldwide.
Natural history studies and patient registries often enrol before drug trials open — contact the Orphanet patient community first.
Patient Resources
Find recruiting Malignant Sertoli-Leydig cell tumor of the ovary trials
Search 500,000+ studies from ClinicalTrials.gov, filtered for Malignant Sertoli-Leydig cell tumor of the ovary. Updated daily.